Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-11

Clinical Trial Update: The Efficacy and Safety of Inpegsomatropin Injection in Children With Idiopathic Short Stature [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the efficacy and safety of Inpegsomatropin injections in children with idiopathic short stature; the study is currently recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Inpegsomatropin (Inpegsomatropin)

Snippet

Sponsor: Xiamen Amoytop Biotech Co., Ltd. | Conditions: Idiopathic Short Stature | Phase 3 | Status: RECRUITING